Please assess the completion status of the following clinical trial:

Trial Title: Opioid Reduction Initiative During Outpatient Pediatric Urologic Procedures Using Exparel

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pediatric patients 6 years and older undergoing minor pediatric urologic surgery~* Patients who are otherwise eligible to receive routine care following minor urologic surgery~Exclusion Criteria:~* Contraindication to receiving local anesthetics (i.e. pre-existing cardiac, renal, hepatic dysfunction)~* Pediatric patients younger than 6 years of age~* Pediatric patients with a history of pain syndromes or are unable to tolerate opiate medication~* Unwilling to participate in 48 hours and 10-14 day follow-up phone calls

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Liposomal Bupivacaine plus 0.25% Bupivacaine (Type: EXPERIMENTAL): Participants will receive local wound infiltration with sequential Liposomal Bupivacaine plus 0.25% Bupivacaine
- 0.25% Bupivacaine alone (Type: ACTIVE_COMPARATOR): Participants will receive local wound infiltration with 0.25% Bupivacaine alone.

Based on this trial design, predict the completion outcome and termination type (if applicable).